Formulation of chitosan nanoparticles loaded with metronidazole for the treatment of infectious diseases

Letters in Drug Design and Discovery

Volumn 7, Issue 2, 2010, Pages 70-78

  Arias, José L ^a   Martínez Soler, Gema I ^a   López Viota, Margarita ^a   Ruiz, Ma Adolfina ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Chitosan; Drug carriers; Drug delivery; Intracellular infections; Metronidazole; Mononuclear phagocyte system

Indexed keywords

CHITOSAN; METRONIDAZOLE; NANOCARRIER; POLOXAMER;

ARTICLE; COLLOID; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; HYDROPHOBICITY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 77949675463     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018010790225831     Document Type: Article

References (39)

1. Couvreur, P.; Vauthier, C. Nanotechnology: Intelligent design to treat complex disease. Pharm. Res., 2006, 23, 1417-1450.
2. Cristescu, R.; Popescu, C.; Popescu, A.; Grigorescu, S.; Mihailescu, I.N.; Mihaiescu, D.; Gittard, S.D.; Narayan, R.J.; Buruiana, T.; Stamatin, I.; Chrisey, D.B. Functional polyethylene glycol derivatives nanostructured thin films synthesized by matrix-assisted pulsed laser evaporation. Appl. Surf. Sci., 2009, 255, 9873-9876.
3. Labhasetwar, V.D.; Dorle, A.K. Nanoparticles - A colloidal drug delivery system for primaquine and metronidazole. J. Control. Release, 1990, 12, 113-119.
4. Ruiz, M.A.; Gallardo, V.; Arias, J.L.; Delgado, A. Effect of latex and plasticizer concentration on glucocorticoid release from ointments. Pharm. Ind., 2003, 65, 454-457.
5. Arias, J.L.; Reddy, L.H.; Couvreur, P. Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine. J. Drug Target, 2009, 17, 586-598.
6. Vauthier, C.; Dubernet, C.; Fattal, E.; Pinto-Alphandary, H.; Couvreur, P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv. Drug Deliv. Rev., 2003, 55, 519-548.
7. Illum, L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res., 1998, 15, 1326-1331.
8. Sinha, V.R.; Singla, A.K.; Wadhawan, S.; Kaushik, R.; Kumria, R.; Bansal, K.; Dhawan, S. Chitosan microspheres as a potential carrier for drugs. Int. J. Pharm., 2004, 274, 1-33.
9. Perioli, L.; Ambrogi, V.; Rubini, D.; Giovagnoli, S.; Ricci, M.; Blasi, P.; Rossi, C. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J. Control. Release, 2004, 95, 521-533.
10. Perioli, L.; Ambrogi, V.; Pagano, C.; Scuota, S.; Rossi, C. FG90 chitosan as a new polymer for metronidazole mucoadhesive tablets for vaginal administration. Int. J. Pharm., 2009, 377, 120-127.
11. Pitt, C.G. The controlled parenteral delivery of polypeptides and proteins. Int. J. Pharm., 1990, 59, 173-196.
12. Thanoo, B.C.; Sunny, M.C.; Jayakrishnan, A. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J. Pharm. Pharmacol., 1992, 44, 283-286.
13. Perioli, L.; Ambrogi, V.; Venezia, L.; Pagano, C.; Ricci, M.; Rossi, C. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels. Colloids Surf. B: Biointerfaces, 2008, 66, 141-145.
14. Lemansky, P.; Hasilik, A. Chondroitin sulfate is involved in lysosomal transport of lysozime in U937 cells. J. Cell Sci., 2001, 114, 345-352.
15. Nordtveit, R.J.; Vårum, K.M.; Smidsrød, O. Degradation of fully watersoluble, partially N-acetylated chitosans with lysozyme. Carbohydr. Polym., 1994, 23, 253-260.
16. Vaidya, A.; Jain, A; Khare, P.; Agrawal, R.K.; Jain, S.K. J. Pharm. Sci., 2009, 98, 4229-36.
17. Bardonnet, P.L.; Faivre, V.; Boullanger, P.; Piffaretti, J.C.; Falson, F. Eur. J. Pharm. Biopharm., 2008, 69, 908-22.
18. Berthold, A.; Cremer, K.; Kreuter, J. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Control. Release, 1996, 39, 17-25.
19. van Oss, C.J. Interfacial Forces in Aqueous Media, 2nd ed.; CRC Press: Boca Raton, 2006.
20. Arias, J.L.; López-Viota, M.; Clares, B.; Ruiz, M.A. Stability of fenbendazole suspensions for veterinary use: Correlation between zeta potential and sedimentation. Eur. J. Pharm. Sci., 2008, 34, 257-262.
21. Arias, J.L.; Gómez-Gallo, A.; Delgado, A.V.; Gallardo, V. Study of the stability of Kollidon® SR suspensions for pharmaceutical applications. Colloids Surf. A: Physicochem. Eng. Aspects, 2009, 338, 107-113.
22. Adamson, A.W.; Gast A.P. Physical chemistry of surfaces, 6th ed.; John Wiley & Sons, Inc.: New York, 1997.
23. O'Brien, R.W.; White, L.R. Electrophoretic mobility of a spherical colloidal particle. J. Chem. Soc. Faraday Trans., 1978, 2, 1607-1626.
24. Elsabee, M.Z.; Morsi, R.E.; Al-Sabagh, A.M. Surface Active Properties of Chitosan and its Derivatives. Colloids Surf. B: Biointerfaces, 2009, 74(1), 1-16.
25. Tyagi, R.; Lala, S.; Verma, A.K.; Nandy, A.K.; Mahato, S.B.; Maitra, A.; Basu, M.K. Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis. J. Drug Target, 2005, 13, 161-171.
26. Weissleder, R.; Bogdanov, A.; Neuwelt, E.A.; Papisov, M. Long-circulating iron oxides for MR imaging. Adv. Drug Deliv. Rev., 1995, 16, 321-334.
27. Chouly, C.; Pouliquen, D.; Lucet, I.; Jeune, J.J.; Jallet, P. Development of superparamagnetic nanoparticles for MRI: Effect of particle size, charge and surface nature on biodistribution. J. Microencapsul., 1996, 13, 245-255.
28. Corot, C.; Robert, P.; Idee, J.M.; Port, M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev., 2006, 58, 1471-1504.
29. Wearley, L.L.; Anthony, G.D. In: Analytical Profiles of Drug Substances; Florey, K., Ed.; Academic Press, Inc.: London, 1976; Vol. 5, pp. 327-344.
30. d) of oxytetracycline, tylosin A, olaquindox and metronidazole in manure. Chemosphere, 2002, 48, 351-361.
31. Machatha, S.G.; Yalkowsky, S.H. Comparison of the octanol/water partition coefficients calculated by ClogP® , ACDlogP and KowWin® to experimentally determined values. Int. J. Pharm., 2005, 294, 185-192.
32. Llovet, M.I.; Egea, M.A.; Valero, J.; Alsina, M.A.; García, M.L.; Chauvet, A. Methotrexate-loaded nanoparticles: analysis of drug content and study of the matrix structure. Drug Dev. Ind. Pharm., 1995, 21, 1761-1771.
33. Arias, J.L.; Gallardo, V.; Ruiz, M.A.; Delgado, A.V. Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres. Int. J. Pharm., 2007, 337, 282-290.
34. Stolnik, S.; Illum, L.; Davis, S.S. Long circulating microparticulate drug carriers. Adv. Drug Deliv. Rev., 1995, 16, 195-214.
35. McCarron, P.A.; Woolfson, A.D.; Keating, S.M. Sustained release of 5-fluorouracil from polymeric nanoparticles. J. Pharm. Pharmacol., 2000, 52, 1451-1459.
36. Ko, J.A.; Park, H.J.; Hwang, S.J.; Park, J.B.; Lee, J.S. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int. J. Pharm., 2002, 249, 165-174.
37. Manca, M.L.; Loy, G.; Zaru, M.; Fadda, A.M.; Antimisiaris, S.G. Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles. Colloids Surf. B: Biointerfaces, 2008, 67, 166-170.
38. Papadimitriou, S.; Bikiaris, D.; Avgoustakis, K.; Karavas, E.; Georgarakis, M. Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr. Polym., 2008, 73, 44-54.
39. Wilson, B.; Samanta, M.K.; Santhi, K.; Kumar, K.P.S.; Ramasamy, M.; Suresh, B. Chitosan nanoparticles as a new delivery system for the anti-Alzheimer's drug tacrine. Nanomedicine NBM, 2009, doi:10.1016/j.nano.2009.04.001. [Epub ahead of print].